Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for those with a history of Type 2 Diabetes and Hypertension and established cardiovascular disease.
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for those with a history of Type 2 Diabetes and Hypertension and established cardiovascular disease.
This study is looking to compare how well the investigational injection acts with existing medication as compared to the medication by itself, in reducing risk of cardiovascular disease and preventing heart failure in at risk patients.
What to Expect
You may qualify if you are:
Adults and adolescents 12 years of age and older living with asthma may qualify for a clinical research study evaluating
Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational
Individuals with bronchiectasis who experience frequent flare-ups or ongoing respiratory symptoms may qualify for a research study evaluating a home
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for
Suburban Research Associates is conducting a clinical research study for adults with Idiopathic Hypersomnia for an upcoming study on daytime